Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Monochiral Center Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.